1-6 of 6
Daniel J. Weisdorf
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Potential of Fecal Microbiota Transplantation to Prevent Acute GVHD: Analysis from a Phase II Trial

Armin Rashidi, Maryam Ebadi, Tauseef Ur Rehman, Heba Elhusseini, David Kazadi, Hossam Halaweish, Mohammad H. Khan, Andrea Hoeschen, Qing Cao, Xianghua Luo, Amanda J. Kabage, Sharon Lopez, Shernan G. Holtan, Daniel J. Weisdorf, Alexander Khoruts, Christopher Staley
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (23): 4920–4929.
https://doi.org/10.1158/1078-0432.CCR-23-2369
Published: 01 December 2023
View article titled, Potential of Fecal Microbiota Transplantation to Prevent Acute GVHD: Analysis from a Phase II Trial
Open the PDF for Potential of Fecal Microbiota Transplantation to Prevent Acute GVHD: Analysis from a Phase II Trial in another window
Includes: Supplementary data
Journal Articles

Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality

Shernan G. Holtan, Constanza Savid-Frontera, Kelly Walton, Anne A. Eaton, Connor Demorest, Andrea Hoeschen, Ling Zhang, Kayla Reid, Tony Kurian, Zena Sayegh, Estefania Julia, Joseph Maakaron, Veronika Bachanova, Najla El Jurdi, Margaret L. MacMillan, Daniel J. Weisdorf, Martin Felices, Jeffrey S. Miller, Bruce R. Blazar, Marco L. Davila, Brian C. Betts
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (6): 1114–1124.
https://doi.org/10.1158/1078-0432.CCR-22-2837
Published: 14 March 2023
View article titled, Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality
Open the PDF for Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality in another window
Includes: Supplementary data
Journal Articles

IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function

Daniel A. Vallera, Martin Felices, Ron McElmurry, Valarie McCullar, Xianzheng Zhou, Joerg Uwe Schmohl, Bin Zhang, Alexander J. Lenvik, Angela Panoskaltsis-Mortari, Michael R. Verneris, Jakub Tolar, Sarah Cooley, Daniel J. Weisdorf, Bruce R. Blazar, Jeffrey S. Miller
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (14): 3440–3450.
https://doi.org/10.1158/1078-0432.CCR-15-2710
Published: 14 July 2016
View article titled, IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33<sup>+</sup> Targets While Also Inducing Persistence, <em>In Vivo</em> Expansion, and Enhanced Function
Open the PDF for IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33<sup>+</sup> Targets While Also Inducing Persistence, <em>In Vivo</em> Expansion, and Enhanced Function in another window
Includes: Supplementary data
Journal Articles

Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia

Michael Boyiadzis, Mukta Arora, John P. Klein, Anna Hassebroek, Michael Hemmer, Alvaro Urbano-Ispizua, Joseph H. Antin, Brian J. Bolwell, Jean-Yves Y. Cahn, Mitchell S. Cairo, Corey S. Cutler, Mary E. Flowers, Robert P. Gale, Roger Herzig, Luis M. Isola, David A. Jacobsohn, Madan H. Jagasia, Thomas R. Klumpp, Stephanie J. Lee, Effie W. Petersdorf, Stella Santarone, Stephen R. Spellman, Harry C. Schouten, Leo F. Verdonck, John R. Wingard, Daniel J. Weisdorf, Mary M. Horowitz, Steven Z. Pavletic
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (9): 2020–2028.
https://doi.org/10.1158/1078-0432.CCR-14-0586
Published: 30 April 2015
View article titled, Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia
Open the PDF for Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia in another window
Includes: Supplementary data
Journal Articles

Phase I Study of a Bispecific Ligand-Directed Toxin Targeting CD22 and CD19 (DT2219) for Refractory B-cell Malignancies

Veronika Bachanova, Arthur E. Frankel, Qing Cao, Dixie Lewis, Bartosz Grzywacz, Michael R. Verneris, Celalettin Ustun, Aleksandr Lazaryan, Brian McClune, Erica D. Warlick, Hagop Kantarjian, Daniel J. Weisdorf, Jeffrey S. Miller, Daniel A. Vallera
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (6): 1267–1272.
https://doi.org/10.1158/1078-0432.CCR-14-2877
Published: 12 March 2015
View article titled, Phase I Study of a Bispecific Ligand-Directed Toxin Targeting CD22 and CD19 (DT2219) for Refractory B-cell Malignancies
Open the PDF for Phase I Study of a Bispecific Ligand-Directed Toxin Targeting CD22 and CD19 (DT2219) for Refractory B-cell Malignancies in another window
Journal Articles

Targeting Natural Killer Cells to Acute Myeloid Leukemia In Vitro with a CD16 × 33 Bispecific Killer Cell Engager and ADAM17 Inhibition

Andres Wiernik, Bree Foley, Bin Zhang, Michael R. Verneris, Erica Warlick, Michelle K. Gleason, Julie A. Ross, Xianghua Luo, Daniel J. Weisdorf, Bruce Walcheck, Daniel A. Vallera, Jeffrey S. Miller
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (14): 3844–3855.
https://doi.org/10.1158/1078-0432.CCR-13-0505
Published: 15 July 2013
View article titled, Targeting Natural Killer Cells to Acute Myeloid Leukemia <em>In Vitro</em> with a CD16 × 33 Bispecific Killer Cell Engager and ADAM17 Inhibition
Open the PDF for Targeting Natural Killer Cells to Acute Myeloid Leukemia <em>In Vitro</em> with a CD16 × 33 Bispecific Killer Cell Engager and ADAM17 Inhibition in another window